Effects of SCA40 on bovine trachealis muscle and on cyclic nucleotide phosphodiesterases

By Pocock T.M.   Laurent F.   Isaac L.M.   Chiu P.   Elliott K.R.F.   Foster R.W.   Michel A.   Bonnet P.-A.   Small R.C.  

European Journal of Pharmacology, Vol. 334, Iss. 1, 1997-09 ,pp. : 75-85

Elsevier

Access to resources Recommend Favorite

Chelerythrine, a protein kinase C inhibitor, interacts with cyclic nucleotide phosphodiesterases

By Eckly-Michel A.E.   Le Bec A.   Lugnier C.  

European Journal of Pharmacology, Vol. 324, Iss. 1, 1997-04 ,pp. : 85-88

Elsevier

Access to resources Recommend Favorite

Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy

By Movsesian Matthew A   Alharethi Rami  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1529-1536

Informa Healthcare

Access to resources Recommend Favorite

Effects of Visnagin on Cyclic Nucleotide Phosphodiesterases and Their Role in its Inhibitory Effects on Vascular Smooth Muscle Contraction - a study with selective inhibitors

By Duarte J.   Lugnier C.   Torres A.I.   Perez-Vizcaino F.   Zarzuelo A.   Tamargo J.  

General Pharmacology, Vol. 32, Iss. 1, 1999-01 ,pp. : 71-74

Elsevier

Access to resources Recommend Favorite

The adipocyte cGMP-inhibited cyclic nucleotide phosphodiesterase (PDE3B) as a target for lipolytic and thermogenic agents for the treatment of obesity

By Snyder P.B.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 587-599

Informa Healthcare

Access to resources Recommend Favorite